Cliff Asness's RCKT Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 3.07 M shares of Rocket Pharmaceuticals, Inc. (RCKT) worth $10.99 M, representing 0.01% of the portfolio. First purchased in 2023-Q4, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in RCKT, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 2.37 M shares. Largest reduction occurred in Q4 2025, reducing 169,719 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Rocket Pharmaceuticals (RCKT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Rocket Pharmaceuticals (RCKT) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +2.37 M | Add 336.36% | 3.07 M | $3.58 |
| Q4 2025 | -169,719 | Reduce 19.44% | 703,528 | $3.51 |
| Q3 2025 | +95,579 | Add 12.29% | 873,247 | $3.26 |
| Q2 2025 | +614,046 | Add 375.28% | 777,668 | $2.45 |
| Q1 2025 | +97,758 | Add 148.42% | 163,622 | $6.67 |
| Q4 2024 | +46,956 | Add 248.34% | 65,864 | $12.57 |
| Q3 2024 | +18,908 | New Buy | 18,908 | $18.47 |
| Q2 2024 | -10,118 | Sold Out | 0 | $0.00 |
| Q1 2024 | +2,060 | Add 25.56% | 10,118 | $26.94 |
| Q4 2023 | +8,058 | New Buy | 8,058 | $29.97 |
Cliff Asness's Rocket Pharmaceuticals Investment FAQs
Cliff Asness first purchased Rocket Pharmaceuticals, Inc. (RCKT) in Q4 2023, acquiring 8,058 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Rocket Pharmaceuticals, Inc. (RCKT) for 10 quarters since Q4 2023.
Cliff Asness's largest addition to Rocket Pharmaceuticals, Inc. (RCKT) was in Q1 2026, adding 3,069,930 shares worth $10.99 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 3,069,930 shares of Rocket Pharmaceuticals, Inc. (RCKT), valued at approximately $10.99 M.
As of the Q1 2026 filing, Rocket Pharmaceuticals, Inc. (RCKT) represents approximately 0.01% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Rocket Pharmaceuticals, Inc. (RCKT) was 3,069,930 shares, as reported at the end of Q1 2026.